Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Operating cash flow
Medtronic PLC's operating cash flow for fiscal 2026 was $7.3B, unchanged from fiscal 2025. Over the twelve months to 31 July 2026 it was $8.0B. Over the past ten years it has ranged from $4.7B (fiscal 2018) to $7.3B (fiscal 2022); the current reading is higher than 92% of that period. Operating cash flow has risen for 3 consecutive fiscal years. Medtronic PLC ranks 2nd of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $7.3B | 4.06% |
| FY2025 | $7.0B | 3.79% |
| FY2024 | $6.8B | 12.39% |
| FY2023 | $6.0B | (17.79%) |
| FY2022 | $7.3B | 17.72% |
| FY2021 | $6.2B | (13.74%) |
| FY2020 | $7.2B | 3.24% |
| FY2019 | $7.0B | 49.59% |
| FY2018 | $4.7B | (31.92%) |
| FY2017 | $6.9B | 31.85% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jul 2026 | $1.8B | (30.31%) |
| Apr 2026 | $2.6B | (6.23%) |
| Jan 2026 | $2.7B | 196.65% |
| Oct 2025 | $925.0M | (14.98%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ABT Abbott Laboratories compare | $9.9B |
| MDT Medtronic PLC | $8.0B |
| SYK Stryker Corporation compare | $5.4B |
| BSX Boston Scientific Corporation compare | $4.2B |
| PHG Koninklijke Philips N.V. compare | $2.9B |
| GEHC GE HealthCare Technologies Inc. compare | $2.4B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc compare | $1.3B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement